CARIS LIFE SCIENCES, INC. Gain (Loss) on Extinguishment of Debt
CARIS LIFE SCIENCES, INC. (CAI) reported Gain (Loss) on Extinguishment of Debt of -$25.23 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-05.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:GainsLossesOnExtinguishmentOfDebt · last filed 2026-08-05
- CARIS LIFE SCIENCES, INC. gain (loss) on extinguishment of debt for the quarter ending 2026-06-30 was -$25.23M.
- CARIS LIFE SCIENCES, INC. gain (loss) on extinguishment of debt for the quarter ending 2025-12-31 was -$1.97M.
- CARIS LIFE SCIENCES, INC. gain (loss) on extinguishment of debt for the quarter ending 2025-09-30 was $0.00.
- CARIS LIFE SCIENCES, INC. gain (loss) on extinguishment of debt for the quarter ending 2025-06-30 was -$17.93M.
- CARIS LIFE SCIENCES, INC. gain (loss) on extinguishment of debt for fiscal 2025 was -$19.89M.
- CARIS LIFE SCIENCES, INC. gain (loss) on extinguishment of debt for fiscal 2024 was $0.00.
- CARIS LIFE SCIENCES, INC. gain (loss) on extinguishment of debt for fiscal 2023 was -$10.91M.
| Period end | Gain (Loss) on Extinguishment of Debt 3 month | Gain (Loss) on Extinguishment of Debt 6 month | Gain (Loss) on Extinguishment of Debt 9 month | Gain (Loss) on Extinguishment of Debt 12 month |
|---|---|---|---|---|
| 2026-06-30 | -$25.23M 10-Q · filed 2026-08-05 | -$25.23M 10-Q · filed 2026-08-05 | ||
| 2025-12-31 | -$1.97M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-03 | -$1.97M derived: sum of 2 quarters · filed 2026-03-03 | -$19.89M derived: sum of 3 quarters · filed 2026-08-05 | -$19.89M 10-K · filed 2026-03-03 |
| 2025-09-30 | $0.00 10-Q · filed 2025-11-05 | -$17.93M derived: sum of 2 quarters · filed 2026-08-05 | -$17.93M 10-Q · filed 2025-11-05 | |
| 2025-06-30 | -$17.93M 10-Q · filed 2026-08-05 | -$17.93M 10-Q · filed 2026-08-05 | ||
| 2024-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-03 | $0.00 derived: sum of 2 quarters · filed 2026-03-03 | $0.00 derived: sum of 3 quarters · filed 2026-03-03 | $0.00 10-K · filed 2026-03-03 |
| 2024-09-30 | $0.00 10-Q · filed 2025-11-05 | $0.00 derived: sum of 2 quarters · filed 2025-11-05 | $0.00 10-Q · filed 2025-11-05 | |
| 2024-06-30 | $0.00 10-Q · filed 2025-08-12 | $0.00 10-Q · filed 2025-08-12 | ||
| 2023-12-31 | -$10.91M 10-K · filed 2026-03-03 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| RadNet, Inc. (RDNT) | United States | $5.611B | -229.65 |
| GRAIL, Inc. (GRAL) | United States | $5.591B | -7.78 |
| VERACYTE, INC. (VCYT) | United States | $3.904B | 41.21 |
| Celcuity Inc. (CELC) | United States | $3.887B | -22.62 |
| CareDx, Inc. (CDNA) | United States | $3.174B | 13.21 |
| Fortrea Holdings Inc. (FTRE) | United States | $1.903B | -19.43 |
| Personalis, Inc. (PSNL) | United States | $1.769B | -13.30 |
| CASTLE BIOSCIENCES INC (CSTL) | United States | $1.074B | -37.45 |
| Lumexa Imaging Holdings, Inc. (LMRI) | United States | $0.951B | |
| Fulgent Genetics, Inc. (FLGT) | United States | $0.593B | -6.70 |